Log In
Print
BCIQ
Print
Print this Print this
 

BGM Galectin-3 test (automated)

  Manage Alerts
Collapse Summary General Information
Company BG Medicine Inc.
DescriptionBlood-based test to measure galectin-3, a soluble beta-galactoside-binding lectin associated with the formation of cardiac fibrosis, in human plasma or serum
Molecular Target Galectin-3 (LGALS3)
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCardiovascular, Diagnostic
Indication DetailsAid in assessing the prognosis of patients with heart failure
Regulatory Designation
Partner Abbott Laboratories; Alere Inc.; bioMerieux S.A.; Siemens AG

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today